SMARCB1 and carcinoma: Among them, 16 were SNUCs, four SMARCB1-deficient sinonasal carcinomas, one SMARCA4-deficient carcinoma, five high-grade neuroendocrine carcinomas, one NC, one TCS, and two sinonasal N-ITAC.